Strategies to Reduce HCV Incidence in Key Populations: The Role of HCV Treatment as Prevention

Strategies to Reduce HCV Incidence in Key Populations: The Role of HCV Treatment as Prevention (July 2019)

Tuesday, July 30, 2019
Webinar -- 1:00 PM ET

Agenda

  • Welcome and Program Overview
  • Key Concepts for Implementation of HCV Treatment as Prevention
  • Question and Answer Session

Faculty

Faculty
Alessio Aghemo, MD, PhD

Associate Professor of Gastroenterology
Department of Biomedical Sciences
Humanitas University
Division of Internal Medicine and Hepatology
Department of Gastroenterology
Humanitas Research Hospital
Milan, Italy

Faculty
Karine Lacombe, MD, PhD

Professor
UMR-S1136
Sorbonne University
Professor
Infectious Diseases Department
St Antoine Hospital
Paris, France

Program Overview
You are invited to attend one of 4 live Webinars during which pairs of European faculty will address your questions regarding HCV treatment as prevention.

Goal Statement
The goal of this activity is to improve participants’ understanding of and competence in implementing principles of HCV treatment as prevention among key patient populations.

Target Audience 
This program is intended for physicians and other healthcare providers, particularly those in France, Germany, Italy, Spain, the United Kingdom, and other European countries, who care for patients with HCV infection.

Learning Objectives 

  • Demonstrate the impact of HCV treatment as prevention on HCV elimination goals nationally and internationally
  • Apply strategies to increase engagement of underserved populations through HCV screening, diagnosis, and treatment programs
  • Implement harm reduction, screening, and support services for at-risk persons following HCV cure

Accreditation

Please note that these Webinars are not certified for CME/CE credit.